ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

1.44
-0.12
(-7.69%)
Cerrado 23 Diciembre 3:00PM
1.45
0.01
( 0.69% )
Pre Mercado: 6:00AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.45
Postura de Compra
1.40
Postura de Venta
1.60
Volume Operado de la Acción
1,297
0.00 Rango del Día 0.00
1.41 Rango de 52 semanas 18.7192
Capitalización de Mercado [m]
Precio Anterior
1.44
Precio de Apertura
-
Última hora de negociación
06:33:02
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,385,405
Acciones en circulación
650,313
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.05
Beneficio por acción (BPA)
-28.96
turnover
148k
Beneficio neto
-18.83M

Acerca de Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Management Consulting Svcs
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.44. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.41 to US$ 18.7192.

Sonnet BioTherapeutics currently has 650,313 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$936,450.72 . Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.05.

SONN Últimas noticias

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic...

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

Continued progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC)  Executed licensing agreement to support initiation of a...

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic...

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level Stable disease (SD) at four months...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.49-25.25773195881.941.941.412848961.58233896CS
4-1.31-47.46376811592.764.851.4129071291.97062976CS
12-4.66-76.26841243866.1110.021.4113854052.56526897CS
26-6.3796-81.48053540417.829610.021.417189532.93774701CS
52-12.31-89.462209302313.7618.71921.414017863.96774602CS
156-1131.99-99.87207086391133.441649.40161.411944577562.75444985CS
260-15324.63-99.990539002815326.0839916.81.4123246142550.04422433CS

SONN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Sonnet BioTherapeutics?
El precio actual de las acciones de Sonnet BioTherapeutics es US$ 1.45
¿Cuántas acciones de Sonnet BioTherapeutics están en circulación?
Sonnet BioTherapeutics tiene 650,313 acciones en circulación
¿Cuál es la capitalización de mercado de Sonnet BioTherapeutics?
La capitalización de mercado de Sonnet BioTherapeutics es USD 936.45k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Sonnet BioTherapeutics?
Sonnet BioTherapeutics ha negociado en un rango de US$ 1.41 a US$ 18.7192 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Sonnet BioTherapeutics?
El ratio precio/beneficio de Sonnet BioTherapeutics es -0.05
¿Cuál es el ratio de efectivo a ventas de Sonnet BioTherapeutics?
El ratio de efectivo a ventas de Sonnet BioTherapeutics es 6.33
¿Cuál es la moneda de reporte de Sonnet BioTherapeutics?
Sonnet BioTherapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Sonnet BioTherapeutics?
El último ingresos anual de Sonnet BioTherapeutics es USD 148k
¿Cuál es el último beneficio anual de Sonnet BioTherapeutics?
El último beneficio anual de Sonnet BioTherapeutics es USD -18.83M
¿Cuál es la dirección registrada de Sonnet BioTherapeutics?
La dirección registrada de Sonnet BioTherapeutics es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Sonnet BioTherapeutics?
La dirección del sitio web de Sonnet BioTherapeutics es www.sonnetbio.com
¿En qué sector industrial opera Sonnet BioTherapeutics?
Sonnet BioTherapeutics opera en el sector MANAGEMENT CONSULTING SVCS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AVGRAvinger Inc
US$ 2.00
(211.33%)
45.32M
BAOSBaosheng Media Group Holdings Ltd
US$ 3.66
(111.56%)
11.22M
CMNDClearmind Medicine Inc
US$ 2.42
(98.36%)
16.2M
TIVCTivic Health Systems Inc
US$ 0.403
(79.59%)
38.75M
ATNF180 Life Sciences Corporation
US$ 3.29
(75.94%)
8.81M
SLGLSol Gel Technologies Ltd
US$ 0.9999
(-39.40%)
539.97k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 14.95
(-32.72%)
1.57k
GLDDGreat Lakes Dredge and Dock Corporation
US$ 9.01
(-21.96%)
2
KALVKalVista Pharmaceuticals Inc
US$ 7.00
(-20.72%)
168
LGHLWLion Group Holding Ltd
US$ 0.006
(-20.00%)
10.02k
SVMHSRIVARU Holding Ltd
US$ 0.032
(14.29%)
138.16M
AVGRAvinger Inc
US$ 2.00
(211.33%)
45.32M
TIVCTivic Health Systems Inc
US$ 0.403
(79.59%)
38.75M
CMNDClearmind Medicine Inc
US$ 2.42
(98.36%)
16.2M
LAESSEALSQ Corporation
US$ 6.25
(27.55%)
16.12M

SONN Discussion

Ver más
tw0122 tw0122 2 semanas hace
Cash out time 5.45 + 150%
👍 1
LowFloatLopes LowFloatLopes 2 semanas hace
I'm at $2.50 out at $4.50 in less than 8 mins lol 
👍️0
tw0122 tw0122 2 semanas hace
Don't stay in long this one hardly ever stays up high long 3.49 +'80%
👍️0
Monksdream Monksdream 2 semanas hace
SONN, 10Q due DEC 13
👍️0
tw0122 tw0122 2 meses hace
Reverse split was September 
👍️0
Invest-in-America Invest-in-America 2 meses hace
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
👍️0
Tiger Money Tiger Money 2 meses hace
What is going on here?  Reverse?  Where is the float on this train wreck now?
👍️0
bigfart bigfart 2 meses hace
So insiders can dump before the RS
👍️0
tw0122 tw0122 2 meses hace
Reverse split offering and now some news $8s
👍️0
tw0122 tw0122 3 meses hace
May the reverse split gods come soon. Keep an eye!
👍️0
BooDog BooDog 3 meses hace
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
👍️0
Clemdane Clemdane 4 meses hace
Big jump today!
👍️0
Awl416 Awl416 4 meses hace
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 4 meses hace
SONN new 52=low
👍️0
Clemdane Clemdane 4 meses hace
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
👍️0
Monksdream Monksdream 4 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 4 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
SONN new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
SONN new 52 week low
👍️0
BooDog BooDog 8 meses hace
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 9 meses hace
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 9 meses hace
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 9 meses hace
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 9 meses hace
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 9 meses hace
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 9 meses hace
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 9 meses hace
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 9 meses hace
Riding free again.
👍️0
Monksdream Monksdream 10 meses hace
SONN under $2
👍️0
crowin crowin 10 meses hace
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 10 meses hace
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 11 meses hace
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 12 meses hace
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
BooDog BooDog 1 año hace
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 1 año hace
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 1 año hace
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 1 año hace
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 1 año hace
You worry about you ok?
👍️0
Monksdream Monksdream 1 año hace
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 1 año hace
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 1 año hace
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 1 año hace
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 1 año hace
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 1 año hace
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0
Monksdream Monksdream 1 año hace
SONN new 52 week low
👍️0